G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 197-204

  Hemstreet III, George P ^a,b,c   Rao, Jian Yu ^a,e   Hurst, Robert E ^a   Bonner, Rebecca B ^a   Waliszewski, Przemko ^a   Grossman, H Barton ^d   Liebert, Monica ^d   Bane, Barbara L ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarkers; cancer risk factor; chemoprevention; G actin; retinoids

Indexed keywords

F ACTIN; G ACTIN; TUMOR MARKER; 4 BIPHENYLAMINE; 4-BIPHENYLAMINE; ACTIN; AMINOBIPHENYL DERIVATIVE; ANTINEOPLASTIC AGENT; BCG VACCINE; CARCINOGEN; DIMETHYL SULFOXIDE;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOGENESIS; PLOIDY; PRIORITY JOURNAL; RISK FACTOR; BLADDER TUMOR; CELL NUCLEUS; CHEMISTRY; REVIEW;

ACTINS; AMINOBIPHENYL COMPOUNDS; ANTICARCINOGENIC AGENTS; BCG VACCINE; CARCINOGENS; CELL NUCLEUS; CLINICAL TRIALS; DIMETHYL SULFOXIDE; HUMANS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0030337957     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<197::AID-JCB28>3.0.CO;2-K     Document Type: Article

References (46)

1. Harris CC (1991): Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 51:5023s-5044s.
2. Rao JY, Hemstreet GP, Hurst RE, Bonner RB, Jones PL, Min KW, Fradet Y (1993): Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci U S A 90:8287-8291.
3. Hemstreet GP, Rao JY, Hurst RE, Bonner RB, Jones PL, Vaidya AM, Fradet Y, Moon RC, Kelloff GJ (1992): Intermediate endpoint biomarkers for chemoprevention. J Cell Biochem Suppl 161:93-110.
4. Hemstreet GP, Schulte PA, Ringen K, Stringer W, Altekruse EB (1988): DNA hyperploidy as a marker for biological response to bladder to carcinogen exposure. Int J Cancer 42:817-820.
5. Tanke H, Brussee J, van Driel-Kulker A, van der Burg M, Schelvis-Knepfle C, Jonas U, Ploem J (1983): Results of the Automated Analysis of 328 Bladder Specimens Using the Leyden Television Analysis System (LEYTAS). World J Urol 1:77-81.
6. West SS, Hemstreet GP, Hurst RE, Bass RA, Doggett RS, Schulte PA (1987): Detection of DNA aneuploidy by quantitative fluorescence image analysis: Potential in screening for occupational bladder cancer. In Dillon K, Ho M (eds): "Biological Monitoring of Exposure to Chemicals." New York City: Wiley, pp 327-341.
7. Golden JF, West SS, Shingleton HM, Murad TM, Echols CK (1979): A screening system for cervical cancer cytology. J Histochem Cytochem 27:522-528.
8. McGowan P, Hurst RE, Bass RE, Hemstreet GP, Postier R (1988): Equilibrium binding of Hoechst 33258 and Hoechst 33342 fluorochromes with rat colorectal cells. J Histochem Cytochem 36:757-762.
9. Bass RA, Hemstreet GP, Honker NA, Hurst RE, Doggett RS (1987): DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patients. Int J Cancer 40(5):698-705.
10. Hemstreet GP, West SS, Weems W, Echols CK, McFarland S, Lewin J, Lindseth G (1983): Quantitative fluorescence measurements of AO-stained normal and malignant bladder cells. Int J Cancer 31:577-585.
11. Rao JY, Hurst RE, Bales WD, Jones PL, Bass RA, Archer LT, Hemstreet GP (1990): Cellular F-actin levels as a marker for cellular transformation: Relationship to cell division and differentiation. Cancer Res 50:2215-2220.
12. Bi W, Rao J, Hemstreet GP, Fang P, Asal NR, Zang M, Min KW, Ma Z, Lee E, Li G, Hurst RE, Bonner RB, Weng Y, Fradet Y, Yin S (1993): Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort. J Occup Med 35(1):20-27.
13. Rhodes S, Hurst RE, Rollins SA, Jones PL, Hemstreet GP, Detrisac CJ, Thomas CF, Moon RC, Kelloff GJ (1991): DNA ploidy and p21 protein levels in tissue sections as end-point markers in animal carcinogenesis trials. Biol Monitor 1:61-73.
14. Jones PL, O'Hare C, Bass RA, Rao JY, Hemstreet GP, Hurst RE (1990): Quantitative immunofluorescence, anti-ras p21 antibody specificity and cellular oncoprotein levels. Biochem Biophys Res Commun 167:464-470.
15. Bonner RB, Hemstreet GP, Fradet Y, Rao JY, Min KW, Hurst RE (1993): Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells. Cancer 72:2461-2469.
16. Hurst RE, Cheung JY, Ashenayi K, Bonner RB, Hemstreet GP (1991): A hybrid image analysis-neural network system for detection of bladder cancer. In: "Proceedings of the Fifth Oklahoma Symposium on Artificial Intelligence," pp 109-112.
17. Rao JY, Hemstreet GP, Hurst RE, Bonner RB, Min KW, Jones PL (1991): Cellular F-actin levels as a marker for cellular transformation: Correlation with bladder cancer risk. Cancer Res 51:2762-2767.
18. Pienta K, Partin A, Coffey DS (1989): Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49:2525-2532.
19. Trosko JE, Chang CC, Madhukar BV, Oh SY (1990): Modulators of gap junction function: The scientific basis of epigenetic toxicology. In Vitro Toxicol 3:9-26.
20. Schlussel RN, Droller MJ, Liu BC (1991): Type IV procollagen mRNA regulation: evidence for extracellular matrix/cytoskeleton/nuclear matrix interactions in human urothelium. J Urol 146:428-432.
21. Pienta KJ, Coffey DS (1992): Type IV procollagen mRNA regulation: Evidence for extracellular matrix/cytoskeleton/nuclear matrix interactions in human urothelium. J Cell Biol 49:357-365.
22. Rao KM, Cohen HJ (1991): Actin cytoskeletal network in aging and cancer. Mutat Res 256:139-148.
23. Pollard T, Cooper JA (1986): Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Annu Rev Biochem 55:987-1035.
24. Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, Wrenn JT, Yamada KM (1971): Microfilaments in cellular and development process. Science 171:135.
25. Miron T, Vancompernolle K, Vandekerckhove J, Wilchek M, Geiger B (1991): A25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J Cell Biol 114:255-261.
26. Shyy TT, Asch BB, Asch HL (1989): Concurrent collapse of keratin filaments, aggregation of organelles, and inhibition of protein synthesis during the heat shock response in mammary epithelial cells. J Cell Biol 108:997-1008.
27. Glass JR, DeWitt RG, Cress AE (1985): Rapid loss of stress fibers in Chinese hamster ovary cells after hyperthermia. Cancer Res 45:258-262.
28. Koyasu S, Kadowaki T, Nishida E, Tobe K, Abe E, Kasuga M, Sakai H, Yahara I (1988): Alteration in growth, cell morphology, and cytoskeletal structures of KB cells induced by epidermal growth factor and transforming growth factor-beta. Exp Cell Res 176:107-116.
29. Dadabay CY, Patton E, Cooper JA, Pike LJ (1991): Lack of correlation between changes in polyphosphoinositide levels and actin/gelsolin complexes in A431 cells treated with epidermal growth factor. J Cell Biol 112:1151-1156.
30. Antecol MH (1988): Oncogenic potential in fibroblasts from individuals genetically predisposed to cancer. Mutat Res 199:293-311.
31. Lombardi L, Ballinari D, Bongarzone I (1990): Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncogene. Cell Motil Cytoskeleton 15:220-229.
32. Paterson HF, Self AJ, Garrett MD, Just I, Aktories K, Hall A (1990): Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol 111:1001-1007.
33. Felice GR, Eason P, Nermut MV, Kellie S (1990): pp60v-src association with the cytoskeleton induces actin reorganization without affecting polymerization status. Eur J Cell Biol 52:47-59.
34. Marchisio PC, Cirillo D, Teti A, Zambonin-Zallone A, Tarone G (1987): Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions. Exp Cell Res 169:202-214.
35. Miller CA, Cohen MD, Costa M (1991): Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis 12:269-276.
36. Scheer U, Hinssen H, Franke WW, Jockusch BM (1984): Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes. Cell 39:111-122.
37. Ankenbauer T, Kleinschmidt JA, Walsh MJ, Weiner OH, Franke WW (1989): Identification of a widespread nuclear actin binding protein. Nature 342:822-825.
38. Lamb NJ, Fernandez A, Watrin A, Labbe JC, Cavadore JC (1990): Microinjection of p34cdc2 kinase induces marked changes in cell shape, cytoskeletal organization, and chromatin structure in mammalian fibroblasts. Cell 60:151-165.
39. Lachapelle M, Aldrich HC (1988): Phalloidin-gold complexes: A new tool for ultrastructural localization of F-actin. J Histochem Cytochem 36:1197-1202.
40. Kolber MA, Broschat KO, Landa-Gonzalez B (1990): Cytochalasin B induces cellular DNA fragmentation. FASEB J 4:3021-3027.
41. Loretz L, Reznikoff CA (1988): Clonal growth of normal human uroepitheleal cells. In Vitro Cell Dev Biol 24: 333-342.
42. Bookland E, Swaminathan S, Oyasu R, Gilchrist K, Lindstrom M, Reznikoff CA (1992): Tumorigenic transformation and neoplastic progression of human uroepithelia cells after exposure in vitro to 4-aminobiphenyl or its metabolites. Cancer Res 52(6):1606-1614.
43. Pratt CI, Kao CH, Wu SQ, Gilchrist KW, Oyasu R, Reznikoff CA (1992): Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells. Cancer Res 52:688-695.
44. Bremer JW, Busch H, Yeoman LC (1981): Evidence for a species of nuclear actin distinct from cytoplasmic and muscles actins. Biochemistry 20:2013-2017.
45. Liebert M, Wedemeyer GA, Stein JA, Washington RW, Jr., Mint A, Ren LQ, Grossman HB (1989): Identification by monoclonal antibodies of an antigen shed by human bladder cancer cell. Cancer Res 49:6720-6726.
46. Sidransky D, Frost P, von Eischenbach AC, Dyasu R, Preisinger AC, Vogelstein B (1992): Clonal origin bladder cancer N Engl J Med 326(11):759-761.